https://www.selleckchem.com/pr....oducts/plerixafor-8h
07% (interquartile range, 14.17%-26.51%). An increasing proportion of marginal donors was not associated with increased center-level OHT volume (R 0.001, p = .833). Marginal donor use was associated with reduced 1- (88.75% vs. 91.87%) and 5-year survival (76.73% vs. 80.08%, p .001). Following adjustment, marginal donor use remained a significant predictor of post-OHT mortality (hazard ratio, 1.17; p .001). Marginal donors account for approximately 20% of OHTs performed in the United States. Despite a redu
Like
Comment
Share
